Behrooz Kasraee is currently the Chief Scientific Officer at Scientis Pharma SA in Geneva, Switzerland, where they have been since 2010. Previously, between 2006 and 2010, they worked as a Dermatologist and Researcher in the Dermatology department at Geneva University Hospital. Kasraee's research focuses on new skin depigmenting molecules, with notable discoveries including Methimazole, Ebselen, and Pyridine derivatives, contributing significantly to the field of dermatology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices